Transgene appoints Hedi Ben Brahim as Chairman and Chief Executive Officer
By nh|2020-12-03T17:32:38+01:00December 3rd, 2020|Press release|Comments Off on Transgene appoints Hedi Ben Brahim as Chairman and Chief Executive Officer
About the Author: nh
Related Posts
- First Head & Neck Cancer Patient Treated in France in a Phase I trial with TG4050 (myvac® Platform), Transgene’s Innovative Individualized Immunotherapy
First Head & Neck Cancer Patient Treated in France in a Phase I trial with TG4050 (myvac® Platform), Transgene’s Innovative Individualized Immunotherapy